✦ LIBER ✦

Pharmacogenomic strategies for cisplatin and pemetrexed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed + cisplatin: first-line for m

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Pemetrexed safety and dosing strategy

✍ Clet Niyikiza; Axel-R Hanauske; James J. Rusthoven; A.Hilary Calvert; Robert All 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Cancer pharmacogenomics: strategies and

✍ Wheeler, Heather E.; Maitland, Michael L.; Dolan, M. Eileen; Cox, Nancy J.; Rata 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 418 KB

Retreatment of recurrent malignant pleur

✍ Hidetoshi Hayashi; Isamu Okamoto; Yasuko Ichikawa; Masaki Miyazaki; Hiroshige Yo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 296 KB

O-56 Symptom and quality of life advanta

✍ Boyer, M.J.; Jassem, J.; Liepa, A.M.; Symanowski, J.T.; Kaukel, E.; Denham, C.A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Comparison of cisplatin plus pemetrexed

✍ Shukuya, Takehito; Takahashi, Toshiaki; Imai, Hisao; Tokito, Takaaki; Ono, Akira 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 398 KB